Cargando…
Progress and Prospects of Anti-HBV Gene Therapy Development
Despite the availability of an effective vaccine against hepatitis B virus (HBV), chronic infection with the virus remains a major global health concern. Current drugs against HBV infection are limited by emergence of resistance and rarely achieve complete viral clearance. This has prompted vigorous...
Autores principales: | Maepa, Mohube B., Roelofse, Ilke, Ely, Abdullah, Arbuthnot, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581210/ https://www.ncbi.nlm.nih.gov/pubmed/26263978 http://dx.doi.org/10.3390/ijms160817589 |
Ejemplares similares
-
Gene Therapy for Chronic HBV—Can We Eliminate cccDNA?
por: Bloom, Kristie, et al.
Publicado: (2018) -
Advances in designing Adeno-associated viral vectors for development of anti-HBV gene therapeutics
por: Mnyandu, Njabulo, et al.
Publicado: (2021) -
Adenoviral Vectors: Potential as Anti-HBV Vaccines and Therapeutics
por: Farhad, Tasneem, et al.
Publicado: (2022) -
Sustained Inhibition of HBV Replication In Vivo after Systemic Injection of AAVs Encoding Artificial Antiviral Primary MicroRNAs
por: Maepa, Mohube Betty, et al.
Publicado: (2017) -
Recent Update on the Role of Circular RNAs in Hepatocellular Carcinoma
por: Ely, Abdullah, et al.
Publicado: (2021)